Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7
1 clinical trials · Condition
◉ Watch Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer (NCT02567422) | National Cancer Institute (NCI) | 2017-04-17 |
Track Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.